French Diagnostics Company Receives FDA Approval for MRSA Test

bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release.

Advertisement

The test detects seven MRSA types and also simultaneously detects two targets, which provides added confidence to the screening results. The EasyQ system supports batch processing of up to 46 MRSA screening tests in a compact space with a turnaround time of three hours.

Read the company news release about NucliSENS EasyQ MRSA.

Related Articles on MRSA:
Patient Safety Tool: Free MRSA Posters and Brochures
Study: Hospital Employees Display Positive Perceptions Toward MRSA Screening Mandates
Study: Antibiotic Linezolid an Effective Treatment for MRSA Infection

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.